TEWKSBURY, Mass.--(BUSINESS WIRE)--Cambridge Heart, Inc. (OTCBB: CAMH), a developer of non-invasive diagnostic tests for cardiac disease, today announced that it has learned that UnitedHealthcare has made the Company’s Microvolt T-Wave Alternans (MTWA) testing a covered benefit for its subscribers. UnitedHealthcare is an operating division of UnitedHealth Group, the largest single health carrier in the United States with more than 32 million medical enrollments.
